Innate T cell immunity to HIV-infection: Immunotherapy with phosphocarbohydrates, a novel strategy of immune intervention?

Vaccine

Volumn 20, Issue 15, 2002, Pages 1938-1941

  Gougeon, M L ^a   Malkovsky, M ^b   Casetti, R ^c   Agrati, C ^c   Poccia, F ^c  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

T cells HIV; Phosphocarbohydrates

Indexed keywords

CARBOHYDRATE DERIVATIVE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; PAMIDRONIC ACID; PHOSPHOCARBOHYDRATE; PHOSPHONIC ACID DERIVATIVE; PROTEINASE INHIBITOR; RANTES; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; ANTIGEN PRESENTATION; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHEMOKINES; DIPHOSPHONATES; HEMITERPENES; HIV INFECTIONS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; LYMPHOKINES; MODELS, IMMUNOLOGICAL; MUCOUS MEMBRANE; ORGANOPHOSPHORUS COMPOUNDS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS;

EID: 0037029903     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00070-1     Document Type: Article

References (28)

1. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
2. 2000. A chemical basis for recognition of nonpeptide antigens by human γδ T cells
3. Vδ1 T cells expanded in the blood throughout HIV infection display a cytotoxic activity and are primed for TNF-α and IFNγ production but are not selected in lymph nodes
4. Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the Vγ9Vδ2 response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons
5. + T cell expansion in the peripheral blood of HIV-infected persons
6. T lymphocyte responses in HIV-1 infection: Implications for vaccine development
7. Regulation of NK cell functions through interaction of the CD94/NKG2 receptors with the nonclassical class I molecule HLA-E
8. Human γδ T cells recognize alkylamines derived from microbes, edible plants, and tea: Implications for innate immunity
9. Human Vγ9Vδ2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites
10. Activation of C-C β-chemokines in human peripheral blood γδ T cells by isopentenyl pyrophosphate and regulation by cytokines
11. Stimulation of γδ T cells by nonpeptidic mycobacterial ligands
12. Selective increase of a subset of T cell receptor γδ T lymphocytes in the peripheral blood of patients with human immunodeficiency virus type 1 infection
13. A subset of γδ T lymphocytes is increased during HIV-1 infection
14. Human γδ T lymphocytes in HIV disease: Effector functions and control by natural killer receptors
15. Immunological and virological effects of long-term IL-2 therapy in HIV-infected patients
16. Stimulation of γδ T-cells by aminobiphosphonates and induction of antiplasma cell activity in multiple myeloma
17. Gamma/delta T-cell stimulation by pamidronate
18. Early activation of human Vγ9Vδ2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands
19. Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: Gammadelta T lymphocytes and natural killer cells
20. Gamma-delta T-cell anergy in human immunodeficiency virus-infected persons with opportunistic infections and recovery after highly active antiretroviral therapy
21. Structured treatment interruptions in HIV infection
22. Evidence for extrathymic changes in the T cell receptor γ/δ repertoire
23. γδ T cells increase with Mycobacterium avium complex infection but not with tuberculosis in AIDS patients
24. Natural T cell immunity to intracellular pathogens and nonpeptidic immunoregulatory drugs
25. Phosphoantigen-reactive Vγ9Vδ2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including C-C chemokines
26. Peripheral Vγ9/Vδ2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1 infected persons
27. Natural and synthetic nonpeptide antigens recognized by human γδ T cells
28. γδ T lymphocytes responses to human immunodeficiency virus